Skip to main content
Top
Published in: BMC Gastroenterology 1/2013

Open Access 01-12-2013 | Research article

Evaluation of the Hepa Wash®treatment in pigs with acute liver failure

Authors: Ahmed Al-Chalabi, Edouard Matevossian, Anne-K v Thaden, Peter Luppa, Albrecht Neiss, Tibor Schuster, Zejian Yang, Catherine Schreiber, Patrick Schimmel, Ewald Nairz, Aurel Perren, Peter Radermacher, Wolfgang Huber, Roland M Schmid, Bernhard Kreymann

Published in: BMC Gastroenterology | Issue 1/2013

Login to get access

Abstract

Background

Mortality of patients with acute liver failure (ALF) is still unacceptably high. Available liver support systems are still of limited success at improving survival. A new type of albumin dialysis, the Hepa Wash® system, was newly introduced. We evaluated the new liver support system as well as the Molecular Adsorbent Recycling System (MARS) in an ischemic porcine model of ALF.

Methods

In the first study animals were randomly allocated to control (n=5) and Hepa Wash (n=6) groups. In a further pilot study, two animals were treated with the MARS-system. All animals received the same medical and surgical procedures. An intraparenchymal intracranial pressure was inserted. Hemodynamic monitoring and goal-directed fluid therapy using the PiCCO system was done. Animals underwent functional end-to-side portacaval shunt and ligation of hepatic arteries. Treatment with albumin dialysis was started after fall of cerebral perfusion pressure to 45 mmHg and continued for 8 h.

Results

All animals in the Hepa Wash group survived the 13-hour observation period, except for one that died after stopping treatment. Four of the control animals died within this period (p=0.03). Hepa Wash significantly reduced impairment of cerebral perfusion pressure (23±2 vs. 10±3 mmHg, p=0.006) and mean arterial pressure (37±1 vs. 24±2 mmHg, p=0.006) but had no effect on intracranial pressure (14±1 vs. 15±1 mmHg, p=0.72). Hepa Wash also enhanced cardiac index (4.94±0.32 vs. 3.36±0.25 l/min/m2, p=0.006) and renal function (urine production, 1850 ± 570 vs. 420 ± 180 ml, p=0.045) and eliminated water soluble (creatinine, 1.3±0.2 vs. 3.2±0.3 mg/dl, p=0.01; ammonia 562±124 vs. 1382±92 μg/dl, p=0.006) and protein-bound toxins (nitrate/nitrite 5.54±1.57 vs. 49.82±13.27 μmol/l, p=0.01). No adverse events that could be attributed to the Hepa Wash treatment were observed.

Conclusions

Hepa Wash was a safe procedure and improved multiorgan system failure in pigs with ALF. The survival benefit could be the result of ameliorating different organ functions in association with the detoxification capacity of water soluble and protein-bound toxins.
Appendix
Available only for authorised users
Literature
1.
go back to reference Stutchfield BM, Simpson K, Wigmore SJ: Systematic review and meta-analysis of survival following extracorporeal liver support. Br J Surg. 2011, 98 (5): 623-631. 10.1002/bjs.7418.CrossRefPubMed Stutchfield BM, Simpson K, Wigmore SJ: Systematic review and meta-analysis of survival following extracorporeal liver support. Br J Surg. 2011, 98 (5): 623-631. 10.1002/bjs.7418.CrossRefPubMed
2.
go back to reference Collins KL, Roberts EA, Adeli K, Bohn D, Harvey EA: Single pass albumin dialysis (SPAD) in fulminant Wilsonian liver failure: a case report. Pediatric nephrology (Berlin, Germany). 2008, 23 (6): 1013-1016. 10.1007/s00467-008-0761-x.CrossRef Collins KL, Roberts EA, Adeli K, Bohn D, Harvey EA: Single pass albumin dialysis (SPAD) in fulminant Wilsonian liver failure: a case report. Pediatric nephrology (Berlin, Germany). 2008, 23 (6): 1013-1016. 10.1007/s00467-008-0761-x.CrossRef
3.
go back to reference Karvellas CJ, Bagshaw SM, McDermid RC, Stollery DE, Bain VG, Gibney RT: A case–control study of single-pass albumin dialysis for acetaminophen-induced acute liver failure. Blood purification. 2009, 28 (3): 151-158. 10.1159/000227280.CrossRefPubMed Karvellas CJ, Bagshaw SM, McDermid RC, Stollery DE, Bain VG, Gibney RT: A case–control study of single-pass albumin dialysis for acetaminophen-induced acute liver failure. Blood purification. 2009, 28 (3): 151-158. 10.1159/000227280.CrossRefPubMed
4.
go back to reference Boonsrirat U, Tiranathanagul K, Srisawat N, Susantitaphong P, Komolmit P, Praditpornsilpa K, Tungsanga K, Eiam-Ong S: Effective bilirubin reduction by single-pass albumin dialysis in liver failure. Artificial organs. 2009, 33 (8): 648-653. 10.1111/j.1525-1594.2009.00758.x.CrossRefPubMed Boonsrirat U, Tiranathanagul K, Srisawat N, Susantitaphong P, Komolmit P, Praditpornsilpa K, Tungsanga K, Eiam-Ong S: Effective bilirubin reduction by single-pass albumin dialysis in liver failure. Artificial organs. 2009, 33 (8): 648-653. 10.1111/j.1525-1594.2009.00758.x.CrossRefPubMed
5.
go back to reference Kreymann B, Seige M, Schweigart U, Kopp KF, Classen M: Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatol. 1999, 31 (6): 1080-1085. 10.1016/S0168-8278(99)80322-5.CrossRefPubMed Kreymann B, Seige M, Schweigart U, Kopp KF, Classen M: Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatol. 1999, 31 (6): 1080-1085. 10.1016/S0168-8278(99)80322-5.CrossRefPubMed
6.
go back to reference Seige M, Kreymann B, Jeschke B, Schweigart U, Kopp KF, Classen M: Long-term treatment of patients with acute exacerbation of chronic liver failure by albumin dialysis. Transplant Proc. 1999, 31 (1–2): 1371-1375.CrossRefPubMed Seige M, Kreymann B, Jeschke B, Schweigart U, Kopp KF, Classen M: Long-term treatment of patients with acute exacerbation of chronic liver failure by albumin dialysis. Transplant Proc. 1999, 31 (1–2): 1371-1375.CrossRefPubMed
7.
go back to reference Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, Berger ED, Lauchart W, Peszynski P, Freytag J: Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl. 2000, 6 (3): 277-286. 10.1053/lv.2000.6355.CrossRefPubMed Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, Berger ED, Lauchart W, Peszynski P, Freytag J: Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl. 2000, 6 (3): 277-286. 10.1053/lv.2000.6355.CrossRefPubMed
8.
go back to reference Schmidt LE, Wang LP, Hansen BA, Larsen FS: Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transpl. 2003, 9 (3): 290-297. 10.1053/jlts.2003.50051.CrossRefPubMed Schmidt LE, Wang LP, Hansen BA, Larsen FS: Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transpl. 2003, 9 (3): 290-297. 10.1053/jlts.2003.50051.CrossRefPubMed
9.
go back to reference El Banayosy A, Kizner L, Schueler V, Bergmeier S, Cobaugh D, Koerfer R: First use of the Molecular Adsorbent Recirculating System technique on patients with hypoxic liver failure after cardiogenic shock. ASAIO J. 2004, 50 (4): 332-337.CrossRefPubMed El Banayosy A, Kizner L, Schueler V, Bergmeier S, Cobaugh D, Koerfer R: First use of the Molecular Adsorbent Recirculating System technique on patients with hypoxic liver failure after cardiogenic shock. ASAIO J. 2004, 50 (4): 332-337.CrossRefPubMed
10.
go back to reference Saliba F, Camus C, Durand F, Mathurin P, Delafosse B, Barange K, Perrigault PF, Revel P, Serfaty L, Belnard M: 220 Predictive factors of transplant free survival in patients with fulminant and subfulminant hepatic failure: Results from a randomized controlled multicenter trial. J Hepatol. 2009, 50 (1): S89-S90. 10.1016/j.jhep.2008.07.029.CrossRef Saliba F, Camus C, Durand F, Mathurin P, Delafosse B, Barange K, Perrigault PF, Revel P, Serfaty L, Belnard M: 220 Predictive factors of transplant free survival in patients with fulminant and subfulminant hepatic failure: Results from a randomized controlled multicenter trial. J Hepatol. 2009, 50 (1): S89-S90. 10.1016/j.jhep.2008.07.029.CrossRef
11.
go back to reference Ellis AJ, Hughes RD, Wendon JA, Dunne J, Langley PG, Kelly JH, Gislason GT, Sussman NL, Williams R: Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology (Baltimore, Md. 1996, 24 (6): 1446-145. 10.1002/hep.510240625.CrossRef Ellis AJ, Hughes RD, Wendon JA, Dunne J, Langley PG, Kelly JH, Gislason GT, Sussman NL, Williams R: Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology (Baltimore, Md. 1996, 24 (6): 1446-145. 10.1002/hep.510240625.CrossRef
12.
go back to reference Sauer IM, Kardassis D, Zeillinger K, Pascher A, Gruenwald A, Pless G, Irgang M, Kraemer M, Puhl G, Frank J: Clinical extracorporeal hybrid liver support–phase I study with primary porcine liver cells. Xenotransplantation. 2003, 10 (5): 460-469. 10.1034/j.1399-3089.2003.00062.x.CrossRefPubMed Sauer IM, Kardassis D, Zeillinger K, Pascher A, Gruenwald A, Pless G, Irgang M, Kraemer M, Puhl G, Frank J: Clinical extracorporeal hybrid liver support–phase I study with primary porcine liver cells. Xenotransplantation. 2003, 10 (5): 460-469. 10.1034/j.1399-3089.2003.00062.x.CrossRefPubMed
13.
go back to reference Sauer IM, Zeilinger K, Pless G, Kardassis D, Theruvath T, Pascher A, Goetz M, Neuhaus P, Gerlach JC: Extracorporeal liver support based on primary human liver cells and albumin dialysis–treatment of a patient with primary graft non-function. J Hepatol. 2003, 39 (4): 649-653. 10.1016/S0168-8278(03)00348-9.CrossRefPubMed Sauer IM, Zeilinger K, Pless G, Kardassis D, Theruvath T, Pascher A, Goetz M, Neuhaus P, Gerlach JC: Extracorporeal liver support based on primary human liver cells and albumin dialysis–treatment of a patient with primary graft non-function. J Hepatol. 2003, 39 (4): 649-653. 10.1016/S0168-8278(03)00348-9.CrossRefPubMed
14.
go back to reference Demetriou AA, Brown RS, Jr Busuttil RW, Fair J, McGuire BM, Rosenthal P, Am Esch JS, Lerut J, Nyberg SL, Salizzoni M: Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Annals of surgery. 2004, 239 (5): 660-667. 10.1097/01.sla.0000124298.74199.e5. discussion 667–670CrossRefPubMedPubMedCentral Demetriou AA, Brown RS, Jr Busuttil RW, Fair J, McGuire BM, Rosenthal P, Am Esch JS, Lerut J, Nyberg SL, Salizzoni M: Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Annals of surgery. 2004, 239 (5): 660-667. 10.1097/01.sla.0000124298.74199.e5. discussion 667–670CrossRefPubMedPubMedCentral
15.
go back to reference Grodzicki M, Kotulski M, Leonowicz D, Zieniewicz K, Krawczyk M: Results of treatment of acute liver failure patients with use of the prometheus FPSA system. Transplant Proc. 2009, 41 (8): 3079-3081. 10.1016/j.transproceed.2009.08.024.CrossRefPubMed Grodzicki M, Kotulski M, Leonowicz D, Zieniewicz K, Krawczyk M: Results of treatment of acute liver failure patients with use of the prometheus FPSA system. Transplant Proc. 2009, 41 (8): 3079-3081. 10.1016/j.transproceed.2009.08.024.CrossRefPubMed
16.
go back to reference Senturk E, Esen F, Ozcan PE, Rifai K, Pinarbasi B, Cakar N, Telci L: The treatment of acute liver failure with fractionated plasma separation and adsorption system: Experience in 85 applications. J Clin Apher. 2010, 25 (4): 195-201. 10.1002/jca.20238.CrossRefPubMed Senturk E, Esen F, Ozcan PE, Rifai K, Pinarbasi B, Cakar N, Telci L: The treatment of acute liver failure with fractionated plasma separation and adsorption system: Experience in 85 applications. J Clin Apher. 2010, 25 (4): 195-201. 10.1002/jca.20238.CrossRefPubMed
17.
go back to reference Bergis D, Friedrich-Rust M, Zeuzem S, Betz C, Sarrazin C, Bojunga J: Treatment of Amanita phalloides intoxication by fractionated plasma separation and adsorption (Prometheus(R)). Journal of gastrointestinal and liver diseases: JGLD. 2012, 21 (2): 171-176.PubMed Bergis D, Friedrich-Rust M, Zeuzem S, Betz C, Sarrazin C, Bojunga J: Treatment of Amanita phalloides intoxication by fractionated plasma separation and adsorption (Prometheus(R)). Journal of gastrointestinal and liver diseases: JGLD. 2012, 21 (2): 171-176.PubMed
18.
go back to reference Al-Chalabi A, Matevossian E, Preissel A, Perren A, Yang Z, Schuster T, Schreiber C, Schimmel P, Nairz E, Yan H: A model of ischemic isolated acute liver failure in pigs: standardizing monitoring and treatment. European surgical research Europaische chirurgische Forschung. 2010, 45 (2): 86-97. 10.1159/000319878.CrossRefPubMed Al-Chalabi A, Matevossian E, Preissel A, Perren A, Yang Z, Schuster T, Schreiber C, Schimmel P, Nairz E, Yan H: A model of ischemic isolated acute liver failure in pigs: standardizing monitoring and treatment. European surgical research Europaische chirurgische Forschung. 2010, 45 (2): 86-97. 10.1159/000319878.CrossRefPubMed
19.
go back to reference Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008, 36 (1): 296-327. 10.1097/01.CCM.0000298158.12101.41.CrossRefPubMed Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008, 36 (1): 296-327. 10.1097/01.CCM.0000298158.12101.41.CrossRefPubMed
20.
go back to reference Marcus R, Eric P, Gabriel KR: On closed testing procedures with special reference to ordered analysis of variance. Biometrika. 1976, 63 (3): 655-660. 10.1093/biomet/63.3.655.CrossRef Marcus R, Eric P, Gabriel KR: On closed testing procedures with special reference to ordered analysis of variance. Biometrika. 1976, 63 (3): 655-660. 10.1093/biomet/63.3.655.CrossRef
21.
go back to reference Sen S, Rose C, Ytrebo LM, Davies NA, Nedredal GI, Drevland SS, Kjonno M, Prinzen FW, Hodges SJ, Deutz NE: Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study. Crit Care Med. 2006, 34 (1): 158-164. 10.1097/01.CCM.0000196203.39832.3C.CrossRefPubMed Sen S, Rose C, Ytrebo LM, Davies NA, Nedredal GI, Drevland SS, Kjonno M, Prinzen FW, Hodges SJ, Deutz NE: Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study. Crit Care Med. 2006, 34 (1): 158-164. 10.1097/01.CCM.0000196203.39832.3C.CrossRefPubMed
22.
go back to reference Ryska M, Laszikova E, Pantoflicek T, Ryska O, Prazak J, Koblihova E: Fractionated plasma separation and adsorption significantly decreases intracranial pressure in acute liver failure: experimental study. European surgical research Europaische chirurgische Forschung. 2009, 42 (4): 230-235. 10.1159/000208790.CrossRefPubMed Ryska M, Laszikova E, Pantoflicek T, Ryska O, Prazak J, Koblihova E: Fractionated plasma separation and adsorption significantly decreases intracranial pressure in acute liver failure: experimental study. European surgical research Europaische chirurgische Forschung. 2009, 42 (4): 230-235. 10.1159/000208790.CrossRefPubMed
23.
go back to reference Desille M, Fremond B, Mahler S, Malledant Y, Seguin P, Bouix A, Lebreton Y, Desbois J, Campion JP, Clement B: Improvement of the neurological status of pigs with acute liver failure by hepatocytes immobilized in alginate gel beads inoculated in an extracorporeal bioartificial liver. Transplant Proc. 2001, 33 (1–2): 1932-1934.CrossRefPubMed Desille M, Fremond B, Mahler S, Malledant Y, Seguin P, Bouix A, Lebreton Y, Desbois J, Campion JP, Clement B: Improvement of the neurological status of pigs with acute liver failure by hepatocytes immobilized in alginate gel beads inoculated in an extracorporeal bioartificial liver. Transplant Proc. 2001, 33 (1–2): 1932-1934.CrossRefPubMed
24.
go back to reference Flendrig LM, Calise F, Di Florio E, Mancini A, Ceriello A, Santaniello W, Mezza E, Sicoli F, Belleza G, Bracco A: Significantly improved survival time in pigs with complete liver ischemia treated with a novel bioartificial liver. The International journal of artificial organs. 1999, 22 (10): 701-709.PubMed Flendrig LM, Calise F, Di Florio E, Mancini A, Ceriello A, Santaniello W, Mezza E, Sicoli F, Belleza G, Bracco A: Significantly improved survival time in pigs with complete liver ischemia treated with a novel bioartificial liver. The International journal of artificial organs. 1999, 22 (10): 701-709.PubMed
25.
go back to reference Wendon J, Lee W: Encephalopathy and cerebral edema in the setting of acute liver failure: pathogenesis and management. Neurocrit Care. 2008, 9 (1): 97-102. 10.1007/s12028-008-9123-6.CrossRefPubMed Wendon J, Lee W: Encephalopathy and cerebral edema in the setting of acute liver failure: pathogenesis and management. Neurocrit Care. 2008, 9 (1): 97-102. 10.1007/s12028-008-9123-6.CrossRefPubMed
26.
go back to reference Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J: Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology (Baltimore, Md. 2007, 46 (6): 1844-1852. 10.1002/hep.21838.CrossRef Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J: Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology (Baltimore, Md. 2007, 46 (6): 1844-1852. 10.1002/hep.21838.CrossRef
27.
go back to reference Malik R, Mookerjee RP, Jalan R: Infection and inflammation in liver failure: two sides of the same coin. J Hepatol. 2009, 51 (3): 426-429. 10.1016/j.jhep.2009.06.013.CrossRefPubMed Malik R, Mookerjee RP, Jalan R: Infection and inflammation in liver failure: two sides of the same coin. J Hepatol. 2009, 51 (3): 426-429. 10.1016/j.jhep.2009.06.013.CrossRefPubMed
28.
go back to reference Ellis A, Wendon J: Circulatory, respiratory, cerebral, and renal derangements in acute liver failure: pathophysiology and management. Seminars in liver disease. 1996, 16 (4): 379-388. 10.1055/s-2007-1007251.CrossRefPubMed Ellis A, Wendon J: Circulatory, respiratory, cerebral, and renal derangements in acute liver failure: pathophysiology and management. Seminars in liver disease. 1996, 16 (4): 379-388. 10.1055/s-2007-1007251.CrossRefPubMed
29.
go back to reference Massion PB, Pelat M, Belge C, Balligand JL: Regulation of the mammalian heart function by nitric oxide. Comparative biochemistry and physiology. 2005, 142 (2): 144-150. 10.1016/j.cbpb.2005.05.048.CrossRefPubMed Massion PB, Pelat M, Belge C, Balligand JL: Regulation of the mammalian heart function by nitric oxide. Comparative biochemistry and physiology. 2005, 142 (2): 144-150. 10.1016/j.cbpb.2005.05.048.CrossRefPubMed
30.
go back to reference Umar S, van der Laarse A: Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart. Mol Cell Biochem. 2010, 333 (1–2): 191-201.CrossRefPubMed Umar S, van der Laarse A: Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart. Mol Cell Biochem. 2010, 333 (1–2): 191-201.CrossRefPubMed
31.
go back to reference Pestana D: Does renal replacement therapy increase mortality in the ICU?. Critical care (London, England). 2011, 15 (2): 415-10.1186/cc10071.CrossRef Pestana D: Does renal replacement therapy increase mortality in the ICU?. Critical care (London, England). 2011, 15 (2): 415-10.1186/cc10071.CrossRef
32.
go back to reference Marmarou A, Shulman K, LaMorgese J: Compartmental analysis of compliance and outflow resistance of the cerebrospinal fluid system. J Neurosurg. 1975, 43 (5): 523-534. 10.3171/jns.1975.43.5.0523.CrossRefPubMed Marmarou A, Shulman K, LaMorgese J: Compartmental analysis of compliance and outflow resistance of the cerebrospinal fluid system. J Neurosurg. 1975, 43 (5): 523-534. 10.3171/jns.1975.43.5.0523.CrossRefPubMed
33.
go back to reference Evenepoel P, Maes B, Wilmer A, Nevens F, Fevery J, Kuypers D, Bammens B, Vanrenterghem Y: Detoxifying capacity and kinetics of the molecular adsorbent recycling system. Contribution of the different inbuilt filters. Blood purification. 2003, 21 (3): 244-252.CrossRefPubMed Evenepoel P, Maes B, Wilmer A, Nevens F, Fevery J, Kuypers D, Bammens B, Vanrenterghem Y: Detoxifying capacity and kinetics of the molecular adsorbent recycling system. Contribution of the different inbuilt filters. Blood purification. 2003, 21 (3): 244-252.CrossRefPubMed
34.
go back to reference Evenepoel P, Laleman W, Wilmer A, Claes K, Maes B, Kuypers D, Bammens B, Nevens F, Vanrenterghem Y: Detoxifying capacity and kinetics of prometheus–a new extracorporeal system for the treatment of liver failure. Blood purification. 2005, 23 (5): 349-358. 10.1159/000086885.CrossRefPubMed Evenepoel P, Laleman W, Wilmer A, Claes K, Maes B, Kuypers D, Bammens B, Nevens F, Vanrenterghem Y: Detoxifying capacity and kinetics of prometheus–a new extracorporeal system for the treatment of liver failure. Blood purification. 2005, 23 (5): 349-358. 10.1159/000086885.CrossRefPubMed
Metadata
Title
Evaluation of the Hepa Wash®treatment in pigs with acute liver failure
Authors
Ahmed Al-Chalabi
Edouard Matevossian
Anne-K v Thaden
Peter Luppa
Albrecht Neiss
Tibor Schuster
Zejian Yang
Catherine Schreiber
Patrick Schimmel
Ewald Nairz
Aurel Perren
Peter Radermacher
Wolfgang Huber
Roland M Schmid
Bernhard Kreymann
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2013
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-13-83

Other articles of this Issue 1/2013

BMC Gastroenterology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.